Renata Past Earnings Performance

Past criteria checks 1/6

Renata's earnings have been declining at an average annual rate of -6.2%, while the Pharmaceuticals industry saw earnings growing at 10.3% annually. Revenues have been growing at an average rate of 9.8% per year. Renata's return on equity is 7.1%, and it has net margins of 6.3%.

Key information

-6.2%

Earnings growth rate

-6.2%

EPS growth rate

Pharmaceuticals Industry Growth11.0%
Revenue growth rate9.8%
Return on equity7.1%
Net Margin6.3%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Renata makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DSE:RENATA Revenue, expenses and earnings (BDT Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2436,4692,29411,0480
31 Dec 2335,6892,14310,7000
30 Sep 2334,0402,11410,1970
30 Jun 2332,9712,3399,6760
31 Mar 2332,5453,67410,0770
31 Dec 2231,6704,4619,4610
30 Sep 2231,7234,9748,7620
30 Jun 2231,0715,1118,3210
31 Mar 2231,8485,5378,3530
31 Dec 2130,7825,4087,5790
30 Sep 2130,3365,2067,6800
30 Jun 2129,9715,0627,6590
31 Mar 2126,6224,5945,6940
31 Dec 2026,5964,4246,2380
30 Sep 2025,1154,3385,8400
30 Jun 2024,6754,0126,0230
31 Mar 2025,7914,3536,7580
31 Dec 1924,2654,1146,5510
30 Sep 1924,0393,9436,5370
30 Jun 1922,2213,8236,0400
31 Mar 1920,6333,4525,6330
31 Dec 1820,2823,3975,4450
30 Sep 1819,5663,2415,0810
30 Jun 1819,0503,1065,0860
31 Mar 1818,9253,0205,0890
31 Dec 1718,2382,8674,6680
30 Sep 1717,7832,8184,5570
30 Jun 1716,6452,6784,2290
31 Mar 1716,1372,5224,0460
31 Dec 1615,4262,4463,8640
30 Sep 1615,6442,4993,4870
30 Jun 1614,7772,2743,7140
31 Mar 1613,5922,1453,5270
31 Dec 1513,4252,0763,4630
30 Sep 1512,5661,9933,2830
30 Jun 1512,2411,9023,1260
31 Mar 1511,7381,7612,9570
31 Dec 1411,4331,6872,8270
30 Sep 1410,6161,5522,4030
30 Jun 1410,1381,5282,2060
31 Mar 149,7091,4442,1530
31 Dec 139,1311,3972,0740
30 Sep 138,9311,3752,1140

Quality Earnings: RENATA has high quality earnings.

Growing Profit Margin: RENATA's current net profit margins (6.3%) are lower than last year (11.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RENATA's earnings have declined by 6.2% per year over the past 5 years.

Accelerating Growth: RENATA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: RENATA had negative earnings growth (-37.6%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-2.8%).


Return on Equity

High ROE: RENATA's Return on Equity (7.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.